Abstract:Optically active 1-phenylethanol and its derivatives are versatile chiral precursors for many pharmaceuticals. The increasing market demand of enantiopure alcohols calls for exploration of more robust biocatalysts capable of delivering high conversion rates at high substrate concentrations. The carbonyl reductase YueD from Bacillus subtilis was engineered for improved reduction of halogenated acetophenones. Based on in silico docking and Alanine screening, mutant Val181Ala with 97% conversion of the model substrate 3-bromoacetophenone was obtained. Further molecular simulation analysis suggested expansion of the catalytic pocket and altered substrate orientation to provide a structural basis for the improved activity upon Vail 81 mutation. To eliminate the requirement of expensive exogenous NADPH and thus afford economical synthesis of enantiopure alcohol products, a cofactor regeneration system based on glucose dehydrogenase was introduced. Since the product of glucose oxidation seemed to inhibit the activity of YueD, xylose was used instead as the co-substrate, which efficiently regenerated NADPH in situ, delivering (S) or (R) alcohols with >99% ee at high conversion rates of 85-99% in the asymmetric reduction of halogenated acetophenones (500 mM). These data demonstrate the industrial potential of the YueD mutant Val181Ala in biosynthesis of valuable chiral alcohols. (C) 2018 Elsevier B.V. All rights reserved.

Process Improvement on Synthesis of Vitamin D2-A and CD Ring Fragment Alcohol

Study on Synthesis of Veratryl Alcohol

Synthesis of an intermediate for A-ring of 19-nor-1α, 25-dihydroxyvitamin D3 analogues

Synthesis of an Optically Active Intermediate for A-ring of 19-nor-1α,25-dihydroxyvitamin D3

Semi-rational Engineering of Carbonyl Reductase YueD for Efficient Biosynthesis of Halogenated Alcohols with in Situ Cofactor Regeneration

Synthesis of 1,2,3-Triazole Bridge-Connected Vitamin D2 Compounds

Synthesis of 4-Acetoxy-2-methyl-2-butenal

Efficient synthesis of 2-ethyl-A-ring analogues of 19-nor-1 alpha,25-dihydroxy vitamin D-3

Efficient synthesis of 2-ethyl-A-ring analogues of 19-nor-1α, 25-dihydroxy vitamin D3

A Novel Synthesis of 19-nor 1Α,25-Dihydroxyvitamin D3 and Related Analogues

Enantioselective Syntheses of Key A-ring Precursors of 1α, 25-Dihydroxyvitamin D3 and Analogues

The Synthesis Of 19-Nor-1 Alpha, 25-Dihydroxy-22-Oxo-Vitamin D-3

Synthesis of Novel C-glycosides Vitamin D2 Derivatives

The Synthesis of 19-Nor-1α, 25-dihydroxy-22-oxo-vitamin D3

A modified synthesis of the antiosteoporosis drug alfacalcidol via a key photochemical transformation of 1α-5,6-Trans-Vitamin D3

A Concise Enantioselective Synthesis of A Key A-Ring Synthon for 1 Alpha-Hydroxyvitamin D-3 Compounds

Economical Process for Preparation of the 19-nor A Ring of Paricalcitol from (−)-Shikimic Acid

Synthesis and evaluation of A-ring diastereomers of 1alpha,25-dihydroxy-22-oxavitamin D3 (OCT).

Highly selective whole-cell 25-hydroxyvitamin D3 synthesis using molybdenum-dependent C25-steroid dehydrogenase and cyclodextrin recycling

Efficient synthesis of novel oxime analogues of the hormone 1 alpha, 25-dihydroxyvitamin D-3

Enantioselective Total Synthesis of (-)-Vinigrol: The Evolution of a Transannular Diels-Alder Strategy